Income Taxes (Tables)

12 Months Ended

Dec. 31, 2013

Income Tax Disclosure [Abstract]

Schedule of Components of Income Tax Expense (Benefit)

	For the Year Ended			For the Period						For the Year Ended
	December 31, 2013			September 29, 2012 to December 31, 2012			January 1, 2012 to September 28, 2012			December 31, 2011
	(Successor)			(Successor)			(Predecessor)			(Predecessor)
Current income tax provision (benefit):
Federal		$19,505			$3,502			$21,795			$3,522
State	187			176			(5,284		)	(6,261		)
Foreign	973			230			833			—
	20,665			3,908			17,344			(2,739		)
Deferred income tax (benefit) provision:
Federal	(79,996		)	(20,660		)	12,982			(7,813		)
State	(1,851		)	(930		)	(829		)	4,556
Foreign	—			—			(50		)	—
	(81,847		)	(21,590		)	12,103			(3,257		)
		($61,182	)		($17,682	)		$29,447			($5,996	)

Schedule of Deferred Tax Assets and (Liabilities)

	December 31, 2013			December 31, 2012
	(Successor)			(Successor)
Deferred tax assets:
Accounts receivable		$35,298			$31,877
Inventories	12,670			8,063
Litigation settlements and contingencies	12,241			8,257
Accrued and prepaid expenses	8,219			8,638
Net operating losses and credit carryforwards	14,019			18,539
Asset impairments	996			1,400
Stock options and restricted shares	4,097			801
Other	4,790			2,560
Total deferred tax assets	92,330			80,135
Deferred tax liabilities:
Fixed assets	(20,621		)	(23,173		)
Deferred financing cost	(15,463		)	—
Intangible assets	(275,399		)	(365,495		)
Other	(1,376		)	(1,096		)
Total deferred tax liabilities	(312,859		)	(389,764		)
Less valuation allowance	(12,322		)	(6,803		)
Net deferred tax (liability) asset		($232,851	)		($316,432	)

Schedule of Effective Income Tax Rate Reconciliation

The table below provides reconciliation between the statutory federal income tax rate and the effective rate of income tax expense for each of the periods shown as follows:

	For the Year Ended	For the Period		For the Year Ended
	December 31, 2013	September 29, 2012 to December 31, 2012	January 1, 2012 to September 28, 2012	December 31, 2011
	(Successor)	(Successor)	(Predecessor)	(Predecessor)
Federal statutory tax rate	35%	35%	35%	35%
State tax – net of federal benefit	1	1	2	2
Change in valuation of deferred tax assets	—	—	—	(9)
Tax contingencies	—	(1)	(6)	8
Non-deductible legal settlements	—	—	17	(14)
Non-deductible annual pharmaceutical manufacturers' fee	(2)	—	—	(5)
Non-deductible transaction costs	—	—	8	(4)
R&D Credit	2	—	—	—
Other	1	—	2	(2)
Effective tax rate	37%	35%	58%	11%

Schedule of Unrecognized Tax Benefits Roll Forward

	For the Year Ended			For the Period					For the Year Ended
	December 31, 2013			September 29, 2012 to December 31, 2012		January 1, 2012 to September 28, 2012			December 31, 2011
	(Successor)			(Successor)		(Predecessor)			(Predecessor)
Balance at the beginning of period		$12,538			$12,119		$14,409			$31,571
Additions based on tax positions related to the current year	2,577			419		2,337			1,779
Additions for tax positions of prior years	3,708			—		634			3,217
Reductions for tax positions of prior years	(842		)	—		(5,261		)	(5,013		)
Reductions due to lapse of applicable statute of limitations	—			—		—			(16,720		)
Settlements paid	—			—		—			(425		)
Balance at the end of the period		$17,981			$12,538		$12,119			$14,409